In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy

Emerging as a potent anticancer treatment, subcellular targeted cancer therapy has drawn increasing attention, bringing great opportunities for clinical application. Here, two targeting strategies for four main subcellular organelles (mitochondria, lysosome, endoplasmic reticulum, and nucleus), incl...

Full description

Saved in:
Bibliographic Details
Published inAdvanced materials (Weinheim) Vol. 35; no. 21; pp. e2209529 - n/a
Main Authors Li, Zheng, Zou, Jianhua, Chen, Xiaoyuan
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Emerging as a potent anticancer treatment, subcellular targeted cancer therapy has drawn increasing attention, bringing great opportunities for clinical application. Here, two targeting strategies for four main subcellular organelles (mitochondria, lysosome, endoplasmic reticulum, and nucleus), including molecule‐ and nanomaterial (inorganic nanoparticles, micelles, organic polymers, and others)‐based targeted delivery or therapeutic strategies, are summarized. Phototherapy, chemotherapy, radiotherapy, immunotherapy, and “all‐in‐one” combination therapy are among the strategies covered in detail. Such materials are constructed based on the specific properties and relevant mechanisms of organelles, enabling the elimination of tumors by inducing dysfunction in the corresponding organelles or destroying specific structures. The challenges faced by organelle‐targeting cancer therapies are also summarized. Looking forward, a paradigm for organelle‐targeting therapy with enhanced therapeutic efficacy compared to current clinical approaches is envisioned. Subcellular targeting is very promising for cancer treatment. The recent progress of subcellular targeting strategies is summarized, concentrating on direct and indirect targeting of four main organelles (mitochondria, lysosome, endoplasm reticulum, and nucleus) on the basis of various formulations. Finally, prospects and challenges of subcellular targeting are also discussed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0935-9648
1521-4095
1521-4095
DOI:10.1002/adma.202209529